 |
PDBsum entry 1ea5
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.3.1.1.7
- acetylcholinesterase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
acetylcholine + H2O = choline + acetate + H+
|
 |
 |
 |
 |
 |
acetylcholine
Bound ligand (Het Group name = )
matches with 41.18% similarity
|
+
|
H2O
|
=
|
choline
|
+
|
acetate
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
Biochemistry
41:10810-10818
(2002)
|
|
PubMed id:
|
|
|
|
|
| |
|
X-ray structures of Torpedo californica acetylcholinesterase complexed with (+)-huperzine A and (-)-huperzine B: structural evidence for an active site rearrangement.
|
|
H.Dvir,
H.L.Jiang,
D.M.Wong,
M.Harel,
M.Chetrit,
X.C.He,
G.Y.Jin,
G.L.Yu,
X.C.Tang,
I.Silman,
D.L.Bai,
J.L.Sussman.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Kinetic and structural data are presented on the interaction with Torpedo
californica acetylcholinesterase (TcAChE) of (+)-huperzine A, a synthetic
enantiomer of the anti-Alzheimer drug, (-)-huperzine A, and of its natural
homologue (-)-huperzine B. (+)-Huperzine A and (-)-huperzine B bind to the
enzyme with dissociation constants of 4.30 and 0.33 microM, respectively,
compared to 0.18 microM for (-)-huperzine A. The X-ray structures of the
complexes of (+)-huperzine A and (-)-huperzine B with TcAChE were determined to
2.1 and 2.35 A resolution, respectively, and compared to the previously
determined structure of the (-)-huperzine A complex. All three interact with the
"anionic" subsite of the active site, primarily through pi-pi stacking and
through van der Waals or C-H.pi interactions with Trp84 and Phe330. Since their
alpha-pyridone moieties are responsible for their key interactions with the
active site via hydrogen bonding, and possibly via C-H.pi interactions, all
three maintain similar positions and orientations with respect to it. The
carbonyl oxygens of all three appear to repel the carbonyl oxygen of Gly117,
thus causing the peptide bond between Gly117 and Gly118 to undergo a peptide
flip. As a consequence, the position of the main chain nitrogen of Gly118 in the
"oxyanion" hole in the native enzyme becomes occupied by the carbonyl of Gly117.
Furthermore, the flipped conformation is stabilized by hydrogen bonding of
Gly117O to Gly119N and Ala201N, the other two functional elements of the
three-pronged "oxyanion hole" characteristic of cholinesterases. All three
inhibitors thus would be expected to abolish hydrolysis of all ester substrates,
whether charged or neutral.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
N.Kitisripanya,
P.Saparpakorn,
P.Wolschann,
and
S.Hannongbua
(2011).
Binding of huperzine A and galanthamine to acetylcholinesterase, based on ONIOM method.
|
| |
Nanomedicine,
7,
60-68.
|
 |
|
|
|
|
 |
Z.F.Al-Rashid,
and
R.P.Hsung
(2011).
(+)-Arisugacin A--computational evidence of a dual binding site covalent inhibitor of acetylcholinesterase.
|
| |
Bioorg Med Chem Lett,
21,
2687-2691.
|
 |
|
|
|
|
 |
Y.F.Shi,
H.Y.Zhang,
W.Wang,
Y.Fu,
Y.Xia,
X.C.Tang,
D.L.Bai,
and
X.C.He
(2009).
Novel 16-substituted bifunctional derivatives of huperzine B: multifunctional cholinesterase inhibitors.
|
| |
Acta Pharmacol Sin,
30,
1195-1203.
|
 |
|
|
|
|
 |
H.Y.Zhang,
H.Yan,
and
X.C.Tang
(2008).
Non-cholinergic effects of huperzine A: beyond inhibition of acetylcholinesterase.
|
| |
Cell Mol Neurobiol,
28,
173-183.
|
 |
|
|
|
|
 |
R.A.Hemendinger,
E.J.Armstrong,
R.Persinski,
J.Todd,
J.L.Mougeot,
F.Volvovitz,
and
J.Rosenfeld
(2008).
Huperzine A provides neuroprotection against several cell death inducers using in vitro model systems of motor neuron cell death.
|
| |
Neurotox Res,
13,
49-61.
|
 |
|
|
|
|
 |
R.Wang,
H.Yan,
and
X.C.Tang
(2006).
Progress in studies of huperzine A, a natural cholinesterase inhibitor from Chinese herbal medicine.
|
| |
Acta Pharmacol Sin,
27,
1.
|
 |
|
|
|
|
 |
T.K.Manojkumar,
C.Cui,
and
K.S.Kim
(2005).
Theoretical insights into the mechanism of acetylcholinesterase-catalyzed acylation of acetylcholine.
|
| |
J Comput Chem,
26,
606-611.
|
 |
|
|
|
|
 |
Y.Umezawa,
and
M.Nishio
(2005).
CH/pi hydrogen bonds as evidenced in the substrate specificity of acetylcholine esterase.
|
| |
Biopolymers,
79,
248-258.
|
 |
|
|
|
|
 |
S.Bencharit,
C.L.Morton,
J.L.Hyatt,
P.Kuhn,
M.K.Danks,
P.M.Potter,
and
M.R.Redinbo
(2003).
Crystal structure of human carboxylesterase 1 complexed with the Alzheimer's drug tacrine: from binding promiscuity to selective inhibition.
|
| |
Chem Biol,
10,
341-349.
|
 |
|
PDB code:
|
 |
|
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |